Yahoo Search Búsqueda en la Web

Resultado de búsqueda

  1. Paul Maxime Nurse (Norwich, 25 de enero de 1949) es un bioquímico británico, ganador del Premio Nobel de Fisiología o Medicina del 2001, conjuntamente con Leland H. Hartwell y R. Timothy Hunt, por sus descubrimientos relativos al papel de las ciclinas y las quinasas dependientes de ciclinas en el ciclo celular.

  2. en.wikipedia.org › wiki › Paul_NursePaul Nurse - Wikipedia

    Paul Nurse. Sir Paul Maxime Nurse OM CH FRS FMedSci HonFREng HonFBA MAE (born 25 January 1949) is an English geneticist, former President of the Royal Society and Chief Executive and Director of the Francis Crick Institute.

  3. 24 de dic. de 2013 · Paul Nurse, galardonado con el Premio Nobel en 2001, es uno de los científicos más brillantes de la historia de la biología. Sus contribuciones han permitido grandes logros en medicina. Nadie...

  4. 25 de abr. de 2024 · Paul Nurse, British scientist who, with Leland H. Hartwell and R. Timothy Hunt, won the Nobel Prize for Physiology or Medicine in 2001 for discovering key regulators of the cell cycle. Nurse’s other awards included the Royal Society’s Copley Medal (2005). Learn more about his life and career.

  5. Sir Paul Nurse Biographical . M y parents were born in Norfolk and spent their early years working in the big houses of that rural English county, my mother as a cook and my father as a handyman and chauffeur. After the 1930s recession they moved to Wembley, North-West London, where my father worked as a mechanic in the local H.J. Heinz food processing factory, and my mother brought up their ...

  6. www.crick.ac.uk › research › find-a-researcherPaul Nurse | Crick

    Paul Nurse is the Chief Executive Officer of the Crick Institute and a Nobel laureate for his work on cell cycle regulation. He studied the cdc2 gene and its human homologue CDK1 in fission yeast and higher organisms.

  7. Sir Paul M. Nurse. The Nobel Prize in Physiology or Medicine 2001. Born: 25 January 1949, Norwich, United Kingdom. Affiliation at the time of the award: Imperial Cancer Research Fund, London, United Kingdom. Prize motivation: “for their discoveries of key regulators of the cell cycle” Prize share: 1/3. Work.